Results 91 to 100 of about 48,980 (246)

Manifestly Unlawful: Why Russian Military Commanders Must Disobey a Nuclear Launch Order Against Ukraine

open access: yes, 2023
Applying the international legal framework governing the use of nuclear weapons to the facts of the war in Ukraine leads to a clear answer to the question of whether the use of nuclear weapons in Ukraine by Russia would be legal.
Hart, Christopher J.
core  

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

open access: yesMolecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain   +10 more
wiley   +1 more source

Wood Gasification: A Promising Strategy to Extend Fuel Reserves after Global Catastrophic Electricity Loss

open access: yesBiomass
It is crucial to increase the resilience of the global food production and distribution systems against the growing concerns relating to factors that could cause global catastrophic infrastructure losses, such as nuclear war or a worldwide pandemic ...
David Nelson   +2 more
doaj   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

The Emerging Powers and the Nuclear Non-Proliferation and Disarmament Regime. Security Policy Brief 27, September 2011 [PDF]

open access: yes, 2011
In this Policy Brief, Tom Sauer looks at the ambivalent position of emerging powers vis-à-vis nuclear non-proliferation and what this eventually means for the ...
Sauer, Tom
core  

Nuclear War Outcomes

open access: yes, 2018
This chapter explores the idea that the nuclear balance of power matters for nuclear war outcomes. It tests this proposition by analyzing simulated nuclear exchanges between the United States and its nuclear-armed rivals: Russia, China, and North Korea ...
Matthew Kroenig
core   +1 more source

Apocalypse now or later? Nuclear war risk perceptions mirroring media coverage and emotional tone shifts in Italian news

open access: yesJudgment and Decision Making
This study delves into the progression of nuclear war risk perceptions during the initial 6 months of the Ukraine war. It particularly investigated the influence of Italian media coverage changes and the affective tone of war representation.
Marco Lauriola   +2 more
doaj   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Interpreting the effects of DNA polymerase variants at the structural level

open access: yesMolecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi   +7 more
wiley   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy